top of page

Mwandishi:

ULY CLINIC

Mhariri:

ULY CLINIC

Imeboreshwa:

2 Machi 2026, 02:55:12

Ludwig’s Angina
Ludwig’s Angina

Ludwig’s Angina

Ludwig’s angina is a rapidly progressive, life-threatening cellulitis involving the bilateral fascial spaces of the floor of the mouth, specifically the submandibular, sublingual, and submental spaces.


Unlike localized abscesses, Ludwig’s angina is characterized by diffuse cellulitis without initial pus formation, resulting in severe tissue edema and elevation of the tongue that may rapidly compromise the airway.


The condition most commonly originates from odontogenic infections, particularly infections of the mandibular second and third molars, whose roots extend below the mylohyoid muscle, allowing direct spread into fascial spaces.


Ludwig’s angina constitutes a true maxillofacial emergency requiring immediate airway assessment, aggressive antimicrobial therapy, and surgical decompression.


Pathophysiology

Infection spreads through fascial planes rather than forming a localized abscess.


Mechanism of spread

  • Dental infection develops in mandibular molars

  • Infection perforates lingual cortical bone

  • Spread occurs above or below the mylohyoid muscle

  • Infection extends bilaterally into fascial spaces

  • Diffuse cellulitis produces inflammatory edema

  • Increased tissue pressure compromises circulation

  • Tongue is displaced upward and backward

  • Progressive airway narrowing develops


Common causative organisms

  • Streptococcus viridans

  • Staphylococcus aureus

  • Peptostreptococcus species

  • Bacteroides species

  • Fusobacterium species

  • Prevotella species

  • Mixed anaerobic oral flora


Risk Factors

  • Untreated dental caries

  • Dental abscess

  • Recent tooth extraction

  • Poor oral hygiene

  • Mandibular trauma

  • Diabetes mellitus

  • Immunosuppression

  • Malnutrition

  • Alcohol abuse

  • Tobacco use


Signs and Symptoms


Local manifestations

  • Pain in the floor of the mouth

  • Rapid bilateral neck swelling

  • Tongue elevation

  • Dysphagia

  • Odynophagia

  • Trismus

  • Drooling of saliva

  • Difficulty speaking

  • Muffled or “hot-potato” voice


Systemic manifestations

  • Fever

  • Chills

  • Malaise

  • Fatigue

  • Tachycardia


Airway danger signs

  • Respiratory distress

  • Stridor

  • Cyanosis

  • Anxiety or restlessness

  • Use of accessory respiratory muscles


Diagnostic Criteria

Diagnosis is mainly clinical and characterized by:

  • Bilateral involvement of submandibular, sublingual and submental spaces

  • Brawny, board-like induration

  • Non-fluctuant swelling

  • Elevated and posteriorly displaced tongue

  • Dysphagia with drooling

  • Respiratory compromise

Advanced disease may demonstrate tissue necrosis during surgical exploration.


Investigations


Clinical assessment

  • Immediate airway evaluation

  • Monitoring of vital signs


Imaging studies

(Performed only after airway stabilization)

  • Contrast-enhanced CT scan of neck

  • MRI when deep tissue involvement is suspected


Laboratory investigations

  • Full blood count showing leukocytosis

  • ESR or CRP elevation

  • Blood glucose testing

  • Renal function tests

  • HIV testing when indicated

  • Culture and sensitivity from drained material


Management

Management follows emergency principles with airway control as priority.


Non-Pharmacological Management

  • Immediate hospital admission

  • Rapid airway assessment

  • Oxygen supplementation

  • Early specialist consultation

  • Surgical decompression of fascial spaces

  • Incision and drainage even without pus

  • Irrigation of infected spaces

  • Removal of offending tooth when possible

  • Placement of surgical drains

  • Adequate hydration

  • Nutritional support

  • Control of systemic diseases


Airway Management

  • Awake fiber-optic intubation where available

  • Emergency tracheostomy if airway obstruction persists

  • Cricothyrotomy in extreme emergencies


Pharmacological Management

(According to Tanzania Standard Treatment Guidelines, 2022)


First-line intravenous therapy

  • Ampicillin 500 mg IV every 6 hours

OR

  • Amoxicillin–clavulanic acid 1.2 g IV every 8 hours

PLUS

  • Metronidazole 500 mg IV every 8 hours

Duration: 5–7 days, followed by oral therapy after improvement.


Severe infection

  • Ceftriaxone 1–2 g IV once daily

  • Metronidazole 500 mg IV every 8 hours


Penicillin allergy

  • Clindamycin 600 mg IV every 8 hours

OR

  • Erythromycin 500 mg orally every 6 hours


Step-down oral therapy

Once swallowing improves:

  • Amoxicillin–clavulanic acid 625 mg orally every 8 hours for 5–7 days


Complications

  • Acute airway obstruction

  • Asphyxia

  • Deep neck space infection

  • Mediastinitis

  • Septicemia

  • Necrotizing fasciitis

  • Aspiration pneumonia

  • Internal jugular vein thrombosis

  • Multi-organ failure

  • Death


Prevention

  • Early treatment of dental infections

  • Regular dental examination

  • Maintenance of oral hygiene

  • Prompt management of mandibular molar infections

  • Proper aseptic dental procedures

  • Good glycemic control in diabetic patients


Patient Education

  • Seek urgent care for neck or mouth swelling

  • Do not ignore dental pain

  • Complete prescribed antibiotics

  • Maintain oral hygiene

  • Attend follow-up appointments

  • Avoid self-medication


Prognosis

Early airway control and aggressive antimicrobial therapy significantly improve survival. Delayed treatment markedly increases morbidity and mortality due to airway obstruction and systemic sepsis.


References

  • Ministry of Health Tanzania. Standard Treatment Guidelines and National Essential Medicines List. 2022 Edition. Dodoma: MoH; 2022.

  • Hupp JR, Ellis E, Tucker MR. Contemporary Oral and Maxillofacial Surgery. 7th ed. Elsevier; 2019.

  • Peterson LJ, Ellis E, Hupp JR, Tucker MR. Peterson’s Principles of Oral and Maxillofacial Surgery. 3rd ed. PMPH-USA; 2012.

  • Flynn TR. Severe odontogenic infections. Oral Maxillofac Surg Clin North Am. 2011;23(3):401-416.

  • Britt JC, Josephson GD, Gross CW. Ludwig’s angina in the pediatric population. Int J Pediatr Otorhinolaryngol. 2000;52(1):79-87.

  • Brook I. Microbiology and management of deep facial infections. J Oral Maxillofac Surg. 2003;61(4):457-462.

  • Boscolo-Rizzo P, Da Mosto MC. Ludwig’s angina: clinical review. Acta Otorhinolaryngol Ital. 2009;29(5):273-279.


Imeandikwa:

4 Novemba 2020, 07:34:38

bottom of page